COVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices)

COVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices)



Qiagen provides molecular testing solutions including instruments, consumables and automation systems for molecular diagnostics, applied testing, pharma and academia markets worldwide. It provides solutions to more than 500,000 customers across the world. Qiagen is a provider of molecular testing solutions. Qiagens product range include Sample Technologies, Assay Technologies, Assay Instruments, Next-Generation Sequencing Consumables, Forensics Sample Collection Consumables and Laboratory and Genomic Services. The report, COVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices) presents a deep dive analysis into how Qiagen NV is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Qiagen NV is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- Net sales for Q3 2020 increased by 26%, likely driven by an ongoing very high level of sales for product groups used in the COVID-19 pandemic response and rapid test kits.
- Qiagen’s production capacity for RNA extraction reagents exceeded to more than the previously expected 10 million patient samples per month. Qiagen is also ramping up its capacity for production of QIAsymphony automation systems and QIAcube processing units due to high demand.
- Qiagen continues its increase in production of QIAstat syndromic system, QIAstat-Dx Respiratory SARS-CoV-2 Panel and NeuMo-Dx in the U.S, Europe and other countries due to its high demand.
- Despite the heavy impact in Europe and the rapid rise of COVID-19 cases in the US, Qiagen saw a significant increase in its total revenue specifically in the Life Science and Molecular segments.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Qiagen NV -
- It provides insights on Qiagen NVs exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Qiagen NV will be affected by the COVID-19 pandemic.


COVID-19 impact analysis on Qiagen NV - Key Findings
Qiagen NV Key Facts
Geographic spread analysis - COVID-19 vs Qiagen NV sales
The impact of COVID-19 on regional GDP per capita levels
Qiagen NV exposure: revenues by region and market vs regional impact levels
Qiagen NV: revenue impact by region and market for 2020
Operational reactions from Qiagen NV? Indications from recruitment trends
Operational reactions from Qiagen NVs’ Indications from US pricing trends
Contact us


Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available